Researchers reported at a latest medical assembly that Xolair, a 20-year-old bronchial asthma drug by Roche and Novartis, considerably diminished allergic reactions in extreme meals
Researchers reported at a latest medical assembly that Xolair, a 20-year-old bronchial asthma drug by Roche and Novartis, considerably diminished allergic reactions in extreme meals